Literature DB >> 23831603

HIV-1 Vpu - an ion channel in search of a job.

Klaus Strebel1.   

Abstract

Vpu is a small membrane protein encoded by HIV-1 and some SIV isolates. The protein is best known for its ability to degrade CD4 and to enhance the release of progeny virions from infected cells. However, Vpu also promotes host-cell apoptosis by deregulating the NFκB signaling pathway and it assembles into cation-conducting membrane pores. This review summarizes our current understanding of these various functions of Vpu with particular emphasis on recent progress in the Vpu field. This article is part of a Special Issue entitled: Viral Membrane Proteins - Channels for Cellular Networking.
© 2013.

Entities:  

Keywords:  BST-2; CD4; HIV-1; Ion channel; Tetherin; Vpu

Mesh:

Substances:

Year:  2013        PMID: 23831603      PMCID: PMC3859730          DOI: 10.1016/j.bbamem.2013.06.029

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  115 in total

1.  Cell type-dependence for Vpu function.

Authors:  R J Geraghty; K J Talbot; M Callahan; W Harper; A T Panganiban
Journal:  J Med Primatol       Date:  1994 Feb-May       Impact factor: 0.667

2.  A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.

Authors:  David R Hout; Lisa M Gomez; Erik Pacyniak; Jean-Marie Miller; M Sarah Hill; Edward B Stephens
Journal:  Virology       Date:  2006-02-03       Impact factor: 3.616

3.  HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.

Authors:  Joëlle V Fritz; Nadine Tibroni; Oliver T Keppler; Oliver T Fackler
Journal:  Virology       Date:  2012-01-04       Impact factor: 3.616

4.  The human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.

Authors:  S Bour; K Strebel
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor.

Authors:  Christine Goffinet; Ina Allespach; Stefanie Homann; Hanna-Mari Tervo; Anja Habermann; Daniel Rupp; Lena Oberbremer; Christian Kern; Nadine Tibroni; Sonja Welsch; Jacomine Krijnse-Locker; George Banting; Hans-Georg Kräusslich; Oliver T Fackler; Oliver T Keppler
Journal:  Cell Host Microbe       Date:  2009-03-19       Impact factor: 21.023

6.  HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin.

Authors:  Naoko Masuyama; Toshio Kuronita; Rika Tanaka; Tomonori Muto; Yuko Hirota; Azusa Takigawa; Hideaki Fujita; Yoshinori Aso; Jun Amano; Yoshitaka Tanaka
Journal:  J Biol Chem       Date:  2009-04-08       Impact factor: 5.157

7.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.

Authors:  Daniel Sauter; Michael Schindler; Anke Specht; Wilmina N Landford; Jan Münch; Kyeong-Ae Kim; Jörg Votteler; Ulrich Schubert; Frederic Bibollet-Ruche; Brandon F Keele; Jun Takehisa; Yudelca Ogando; Christina Ochsenbauer; John C Kappes; Ahidjo Ayouba; Martine Peeters; Gerald H Learn; George Shaw; Paul M Sharp; Paul Bieniasz; Beatrice H Hahn; Theodora Hatziioannou; Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2009-11-19       Impact factor: 21.023

8.  Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.

Authors:  U Schubert; K A Clouse; K Strebel
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction.

Authors:  Tonya Kueck; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

10.  Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach.

Authors:  Takeshi Yoshida; Sandra Kao; Klaus Strebel
Journal:  Front Microbiol       Date:  2011-02-18       Impact factor: 5.640

View more
  24 in total

1.  HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Authors:  Vijaya Madhavi; Bruce D Wines; Janaki Amin; Sean Emery; Ester Lopez; Anthony Kelleher; Rob J Center; P Mark Hogarth; Amy W Chung; Stephen J Kent; Ivan Stratov
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

Review 2.  Relating structure and function of viral membrane-spanning miniproteins.

Authors:  Stanley J Opella
Journal:  Curr Opin Virol       Date:  2015-06-06       Impact factor: 7.090

3.  Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.

Authors:  Dominique Dotson; Elvin A Woodruff; Fernando Villalta; Xinhong Dong
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

4.  HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.

Authors:  Raymond A Alvarez; Rebecca E Hamlin; Anthony Monroe; Brian Moldt; Mathew T Hotta; Gabriela Rodriguez Caprio; Daniel S Fierer; Viviana Simon; Benjamin K Chen
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

5.  Novel Acylguanidine-Based Inhibitor of HIV-1.

Authors:  Philip Mwimanzi; Ian Tietjen; Scott C Miller; Aniqa Shahid; Kyle Cobarrubias; Natalie N Kinloch; Bemuluyigza Baraki; Jonathan Richard; Andrés Finzi; David Fedida; Zabrina L Brumme; Mark A Brockman
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

6.  Screening of the Pan-African natural product library identifies ixoratannin A-2 and boldine as novel HIV-1 inhibitors.

Authors:  Ian Tietjen; Fidele Ntie-Kang; Philip Mwimanzi; Pascal Amoa Onguéné; Margaret A Scull; Thomas Oyebode Idowu; Abiodun Oguntuga Ogundaini; Luc Mbaze Meva'a; Berhanu M Abegaz; Charles M Rice; Kerstin Andrae-Marobela; Mark A Brockman; Zabrina L Brumme; David Fedida
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

7.  Atomistic detailed mechanism and weak cation-conducting activity of HIV-1 Vpu revealed by free energy calculations.

Authors:  Siladitya Padhi; Raghunadha Reddy Burri; Shahid Jameel; U Deva Priyakumar
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

8.  Membrane protein assembly: two cytoplasmic phosphorylated serine sites of Vpu from HIV-1 affect oligomerization.

Authors:  Chin-Pei Chen; Meng-Han Lin; Ya-Ting Chan; Li-Chyong Chen; Che Ma; Wolfgang B Fischer
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

Review 9.  HIV-1 Hijacking of Host ATPases and GTPases That Control Protein Trafficking.

Authors:  Lucas A Tavares; Yunan C Januário; Luis L P daSilva
Journal:  Front Cell Dev Biol       Date:  2021-07-08

Review 10.  Arms Race between Enveloped Viruses and the Host ERAD Machinery.

Authors:  Dylan A Frabutt; Yong-Hui Zheng
Journal:  Viruses       Date:  2016-09-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.